VANTIA LTD has a total of 103 patent applications. Its first patent ever was published in 1996. It filed its patents most often in EPO (European Patent Office), Australia and United Kingdom. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are BEIJING MOLECULE SCIENCE AND T, CGI PHARMACEUTICALS INC and BOEHRINGER INGELHEIM ITALIA.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 10 | |
#2 | Australia | 9 | |
#3 | United Kingdom | 8 | |
#4 | Canada | 7 | |
#5 | WIPO (World Intellectual Property Organization) | 7 | |
#6 | Argentina | 6 | |
#7 | China | 5 | |
#8 | Republic of Korea | 5 | |
#9 | Hungary | 4 | |
#10 | Israel | 4 | |
#11 | Taiwan | 4 | |
#12 | United States | 4 | |
#13 | Brazil | 3 | |
#14 | Czechia | 3 | |
#15 | Hong Kong | 3 | |
#16 | Mexico | 3 | |
#17 | Uruguay | 3 | |
#18 | Poland | 2 | |
#19 | Russian Federation | 2 | |
#20 | Colombia | 1 | |
#21 | Ecuador | 1 | |
#22 | Croatia | 1 | |
#23 | Japan | 1 | |
#24 | Montenegro | 1 | |
#25 | Malaysia | 1 | |
#26 | Norway | 1 | |
#27 | New Zealand | 1 | |
#28 | Serbia | 1 | |
#29 | Slovakia | 1 | |
#30 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Heterocyclic compounds | |
#3 | Medical preparations | |
#4 | Organic chemistry methods | |
#5 | Acyclic or carbocyclic compounds | |
#6 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Evans David Michael | 32 |
#2 | Hudson Peter | 28 |
#3 | Allan Christine Elizabeth | 20 |
#4 | Roe Michael Bryan | 18 |
#5 | Pitt Gary Robert William | 16 |
#6 | Baxter Andrew John | 15 |
#7 | Stockley Martin Lee | 15 |
#8 | Handy Rachel | 15 |
#9 | Rooker David Philip | 15 |
#10 | Andrzej Roman Batt | 14 |
Publication | Filing date | Title |
---|---|---|
GB201105537D0 | New process | |
GB201005623D0 | New polymorph | |
GB201004677D0 | New salt | |
GB0918924D0 | Azaindole derivatives | |
GB0918922D0 | Aminopyridine derivatives | |
GB0918923D0 | Aminothiazole derivatives | |
GB0903493D0 | New compounds | |
GB0807828D0 | Aminopyridine derivatives | |
TWI307338B | Novel antidiuretic agents |